Quick Answer
Zhengye Biotechnology Holding Ltd reported Stockholders Equity of $283.96 million for fiscal year 2024.
Zhengye Biotechnology Holding Ltd Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $283.96M | +4.1% |
| 2023 | $272.85M | -23.5% |
| 2022 | $356.87M | +11.9% |
| 2021 | $318.84M | — |
- Zhengye Biotechnology Holding Ltd showed an increase of +4.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2021–2024 period, Zhengye Biotechnology Holding Ltd’s stockholders equity has declined by 10.9% (from $318.84 million to $283.96 million).
- The most recent figure is from Zhengye Biotechnology Holding Ltd’s fiscal year 2024 report (Form 20-F), filed with the SEC on July 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: